866-997-4948(US-Canada Toll Free)

United States Hemostatic Agents Market Report 2016

Published By :

QYResearch

Published Date : Dec 2016

Category :

Pharmaceutical

No. of Pages : 95 Pages

Notes:
Sales, means the sales volume of Hemostatic Agents
Revenue, means the sales value of Hemostatic Agents

This report studies sales (consumption) of Hemostatic Agents in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Baxter International Inc.
Johnson & Johnson
C.R. BARD, Inc.
Covidien PLC.
Sanofi Group
B. Braun Melsungen AG
Atrium Medical Corporation
Cryolife, Inc.
Hemostasis, LLC
Stryker Corporation

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Hemostatic Agents in each application, can be divided into
Application 1
Application 2
Application 3

Table of Contents

United States Hemostatic Agents Market Report 2016
1 Hemostatic Agents Overview
1.1 Product Overview and Scope of Hemostatic Agents
1.2 Classification of Hemostatic Agents
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Hemostatic Agents
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Hemostatic Agents (2011-2021)
1.4.1 United States Hemostatic Agents Sales and Growth Rate (2011-2021)
1.4.2 United States Hemostatic Agents Revenue and Growth Rate (2011-2021)

2 United States Hemostatic Agents Competition by Manufacturers
2.1 United States Hemostatic Agents Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Hemostatic Agents Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Hemostatic Agents Average Price by Manufactures (2015 and 2016)
2.4 Hemostatic Agents Market Competitive Situation and Trends
2.4.1 Hemostatic Agents Market Concentration Rate
2.4.2 Hemostatic Agents Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Hemostatic Agents Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Hemostatic Agents Sales and Market Share by Type (2011-2016)
3.2 United States Hemostatic Agents Revenue and Market Share by Type (2011-2016)
3.3 United States Hemostatic Agents Price by Type (2011-2016)
3.4 United States Hemostatic Agents Sales Growth Rate by Type (2011-2016)

4 United States Hemostatic Agents Sales (Volume) by Application (2011-2016)
4.1 United States Hemostatic Agents Sales and Market Share by Application (2011-2016)
4.2 United States Hemostatic Agents Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Hemostatic Agents Manufacturers Profiles/Analysis
5.1 Baxter International Inc.
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Hemostatic Agents Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Baxter International Inc. Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Johnson & Johnson
5.2.2 Hemostatic Agents Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Johnson & Johnson Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 C.R. BARD, Inc.
5.3.2 Hemostatic Agents Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 C.R. BARD, Inc. Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Covidien PLC.
5.4.2 Hemostatic Agents Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Covidien PLC. Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi Group
5.5.2 Hemostatic Agents Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi Group Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 B. Braun Melsungen AG
5.6.2 Hemostatic Agents Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 B. Braun Melsungen AG Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Atrium Medical Corporation
5.7.2 Hemostatic Agents Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Atrium Medical Corporation Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Cryolife, Inc.
5.8.2 Hemostatic Agents Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Cryolife, Inc. Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Hemostasis, LLC
5.9.2 Hemostatic Agents Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Hemostasis, LLC Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Stryker Corporation
5.10.2 Hemostatic Agents Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Stryker Corporation Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview

6 Hemostatic Agents Manufacturing Cost Analysis
6.1 Hemostatic Agents Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Hemostatic Agents

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Hemostatic Agents Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Hemostatic Agents Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Hemostatic Agents Market Forecast (2016-2021)
10.1 United States Hemostatic Agents Sales, Revenue Forecast (2016-2021)
10.2 United States Hemostatic Agents Sales Forecast by Type (2016-2021)
10.3 United States Hemostatic Agents Sales Forecast by Application (2016-2021)
10.4 Hemostatic Agents Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Hemostatic Agents
Table Classification of Hemostatic Agents
Figure United States Sales Market Share of Hemostatic Agents by Type in 2015
Table Application of Hemostatic Agents
Figure United States Sales Market Share of Hemostatic Agents by Application in 2015
Figure United States Hemostatic Agents Sales and Growth Rate (2011-2021)
Figure United States Hemostatic Agents Revenue and Growth Rate (2011-2021)
Table United States Hemostatic Agents Sales of Key Manufacturers (2015 and 2016)
Table United States Hemostatic Agents Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Hemostatic Agents Sales Share by Manufacturers
Figure 2016 Hemostatic Agents Sales Share by Manufacturers
Table United States Hemostatic Agents Revenue by Manufacturers (2015 and 2016)
Table United States Hemostatic Agents Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Hemostatic Agents Revenue Share by Manufacturers
Table 2016 United States Hemostatic Agents Revenue Share by Manufacturers
Table United States Market Hemostatic Agents Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Hemostatic Agents Average Price of Key Manufacturers in 2015
Figure Hemostatic Agents Market Share of Top 3 Manufacturers
Figure Hemostatic Agents Market Share of Top 5 Manufacturers
Table United States Hemostatic Agents Sales by Type (2011-2016)
Table United States Hemostatic Agents Sales Share by Type (2011-2016)
Figure United States Hemostatic Agents Sales Market Share by Type in 2015
Table United States Hemostatic Agents Revenue and Market Share by Type (2011-2016)
Table United States Hemostatic Agents Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Hemostatic Agents by Type (2011-2016)
Table United States Hemostatic Agents Price by Type (2011-2016)
Figure United States Hemostatic Agents Sales Growth Rate by Type (2011-2016)
Table United States Hemostatic Agents Sales by Application (2011-2016)
Table United States Hemostatic Agents Sales Market Share by Application (2011-2016)
Figure United States Hemostatic Agents Sales Market Share by Application in 2015
Table United States Hemostatic Agents Sales Growth Rate by Application (2011-2016)
Figure United States Hemostatic Agents Sales Growth Rate by Application (2011-2016)
Table Baxter International Inc. Basic Information List
Table Baxter International Inc. Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter International Inc. Hemostatic Agents Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Hemostatic Agents Sales Market Share (2011-2016)
Table C.R. BARD, Inc. Basic Information List
Table C.R. BARD, Inc. Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table C.R. BARD, Inc. Hemostatic Agents Sales Market Share (2011-2016)
Table Covidien PLC. Basic Information List
Table Covidien PLC. Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Covidien PLC. Hemostatic Agents Sales Market Share (2011-2016)
Table Sanofi Group Basic Information List
Table Sanofi Group Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Group Hemostatic Agents Sales Market Share (2011-2016)
Table B. Braun Melsungen AG Basic Information List
Table B. Braun Melsungen AG Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table B. Braun Melsungen AG Hemostatic Agents Sales Market Share (2011-2016)
Table Atrium Medical Corporation Basic Information List
Table Atrium Medical Corporation Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Atrium Medical Corporation Hemostatic Agents Sales Market Share (2011-2016)
Table Cryolife, Inc. Basic Information List
Table Cryolife, Inc. Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cryolife, Inc. Hemostatic Agents Sales Market Share (2011-2016)
Table Hemostasis, LLC Basic Information List
Table Hemostasis, LLC Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hemostasis, LLC Hemostatic Agents Sales Market Share (2011-2016)
Table Stryker Corporation Basic Information List
Table Stryker Corporation Hemostatic Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stryker Corporation Hemostatic Agents Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hemostatic Agents
Figure Manufacturing Process Analysis of Hemostatic Agents
Figure Hemostatic Agents Industrial Chain Analysis
Table Raw Materials Sources of Hemostatic Agents Major Manufacturers in 2015
Table Major Buyers of Hemostatic Agents
Table Distributors/Traders List
Figure United States Hemostatic Agents Production and Growth Rate Forecast (2016-2021)
Figure United States Hemostatic Agents Revenue and Growth Rate Forecast (2016-2021)
Table United States Hemostatic Agents Production Forecast by Type (2016-2021)
Table United States Hemostatic Agents Consumption Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *